-
-
-
-
-
-
-
Kura Oncology publishes ziftomenib combination study in Blood journal
-
-
-
-
-
-
-
Kura Oncology (KURA) PT Lowered to $25 at Mizuho
-
-
-
-
-
-
-
Kura Oncology reports combination trial data for KOMZIFTI with venetoclax
-
-
-
-
-
-
-
Kura Oncology (KURA) halted, news pending
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)
-
-
-
-
-
-
-
Kura Oncology presents preclinical data on drug combination therapy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)
-
435,178 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

